GNRH1 and leiomyoma: There are few therapies approved by the US Food and Drug Administration (FDA) for the treatment of fibroids: gonadotropin-releasing hormone (GNRH) agonists, recently approved GNRH antagonists, embolic agents for uterine artery embolization, magnetic resonance imaging-guided high-energy focused ultrasound ablation, and surgery [15].